Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | MME | P08473 | 2/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9617696 | 1.00 | LTA4H (0.55) | LTA4HMMEOPRM1OPRD1OPRK1 | |
| SCHEMBL27691470 | 1.00 | LTA4H (0.55) | LTA4HMMEOPRM1OPRD1OPRK1 | |
| SCHEMBL30517753 | 0.96 | LTA4H (0.53) | LTA4HMME | |
| SCHEMBL30799848 | 0.92 | OPRM1 (0.54) | LTA4HMMEOPRM1OPRD1OPRK1 | |
| SCHEMBL30728889 | 0.92 | MME (0.50) | LTA4HMME | |
| SCHEMBL29531754 | 0.92 | MME (0.50) | LTA4HMME | |
| SCHEMBL29705780 | 0.92 | OPRD1 (0.54) | OPRM1OPRD1OPRK1 | |
| SCHEMBL34470345 | 0.92 | MME (0.42) | LTA4HMMEOPRM1OPRD1OPRK1 | |
| SCHEMBL30400489 | 0.91 | NPY4R (0.52) | LTA4HOPRM1OPRD1 | |
| SCHEMBL31259942 | 0.91 | MME (0.47) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4058898-A | — | — | None | — | — | JP | disclosed |
| US-20250242039-A1 | TOXIN-DERIVED DELIVERY CONSTRUCTS | THORNHILL THERAPEUTICS INC (US) | 2025-07-31 | — | — | US | disclosed |
| US-20240226243-A9 | CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO | THORNHILL THERAPEUTICS, INC. | 2024-07-11 | — | — | US | disclosed |
| US-20240207372-A1 | CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO | APPLIED MOLECULAR TRANSPORT INC. | 2024-06-27 | — | — | US | disclosed |
| US-20240131118-A1 | CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO | APPLIED MOLECULAR TRANSPORT INC (US) | 2024-04-25 | — | — | US | disclosed |
| JP-H0458898-A | TRIPEPTIDE AND ACTIVITY MEASUREMENT OF ANGIOTENSIN-CONVERSION ENZYME USING SAME COMPOUND | FUJIREBIO INC | 1992-02-25 | — | — | JP | disclosed |